Duloxetine for the Treatment of Dysthymia.

Trial Profile

Duloxetine for the Treatment of Dysthymia.

Phase of Trial: Phase IV

Latest Information Update: 14 Apr 2009

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Dysthymic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Apr 2009 Actual end date (Apr 2006) added as reported by ClinicalTrials.gov.
    • 14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Apr 2009 Planned end date changed from 1 Apr 2006 to 1 Dec 2006 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top